- Home
- UAN vs SANA Comparison
UAN vs SANA Comparison
Compare UAN & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAN
- SANA
- Stock Information
- Founded
- UAN 2007
- SANA 2018
- Country
- UAN United States
- SANA United States
- Employees
- UAN N/A
- SANA N/A
- Industry
- UAN Agricultural Chemicals
- SANA Medicinal Chemicals and Botanical Products
- Sector
- UAN Industrials
- SANA Health Care
- Exchange
- UAN Nasdaq
- SANA Nasdaq
- Market Cap
- UAN 1.0B
- SANA 983.4M
- IPO Year
- UAN 2011
- SANA 2021
- Fundamental
- Price
- UAN $100.10
- SANA $4.08
- Analyst Decision
- UAN
- SANA Strong Buy
- Analyst Count
- UAN 0
- SANA 7
- Target Price
- UAN N/A
- SANA $8.00
- AVG Volume (30 Days)
- UAN 29.0K
- SANA 6.7M
- Earning Date
- UAN 10-29-2025
- SANA 11-11-2025
- Dividend Yield
- UAN 6.79%
- SANA N/A
- EPS Growth
- UAN 141.96
- SANA N/A
- EPS
- UAN 12.04
- SANA N/A
- Revenue
- UAN $614,528,000.00
- SANA N/A
- Revenue This Year
- UAN N/A
- SANA N/A
- Revenue Next Year
- UAN N/A
- SANA N/A
- P/E Ratio
- UAN $8.23
- SANA N/A
- Revenue Growth
- UAN 16.52
- SANA N/A
- 52 Week Low
- UAN $63.45
- SANA $1.26
- 52 Week High
- UAN $99.77
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- UAN 74.78
- SANA 42.70
- Support Level
- UAN $91.44
- SANA $5.12
- Resistance Level
- UAN $95.00
- SANA $5.00
- Average True Range (ATR)
- UAN 2.03
- SANA 0.41
- MACD
- UAN 0.78
- SANA -0.21
- Stochastic Oscillator
- UAN 92.93
- SANA 22.44
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.